• secy.pho@gmail.com
  • Pediatric Hematology Oncology Journal
  • Membership
  • Photo Gallery
  • Login
  • Register
Logo
  • Home
  • About
    • PHO Introduction
    • Constitution
    • Message from Chairperson
    • Office Bearers 2025-2026
    • Office Bearers 2024-2025
    • Office Bearers 2022-2023
    • Office Bearers 2018-2019
    • Office Bearers 2017-2018
    • 20 Years of Glory
    • Archives
    • Job Vacancy
    • Hall of Fame
  • Member
    • GBM Minutes
    • Meeting SOPs
    • Presentations
    • Education Books
    • R K Marwaha Traveling Scholarship
    • PHO Oration List
    • PHO Vibes
    • NTP-PPH
    • NTP-PPO
    • Grants & Awards
    • INPHOG
    • Research
  • Events
    • Upcoming Events
    • Phocons Through The Years
  • Knowledge Centre
    • Links
    • Journals
    • Asia Cancer Resource Directory
    • Webcasts & E-Posters
    • Parental Guidelines
    • WLPO- Almanac 2023
    • IAP PHO Guidelines
    • Thalassemia Guideline- PHO Chapter 2023
  • Payment
    • ICP PHO Fellowship Payment
    • Membership Payment
PHO India

Login

Please fill out the following information to login:

Forgot password ? Reset It.
Not a member yet? Register.
RSC IT CLUB

Welcome back!

Please fill out your email. A link to reset password will be sent there.

Back to login

RSC IT CLUB

Register

In order to be a life member of the PHO Chapter, one has to be a Life member of Indian Academy of Paediatrics (IAP) and have keen interest in paediatric haematology and oncology as evidenced by papers on the subject, hands on training in PHO or active involvement in caring for children with haematology oncology disorders. On being elected as life member, one is eligible for all benefits of the chapter including voting rights, standing for election and holding office in the chapter.
Students undergoing training in Paediatrics, having Associate Life Membership of IAP, but not yet eligible for full Life Membership of IAP and keenly interested in paediatric haematology and oncology, are eligible for Associate Life Membership of the PHO Chapter. On completion of training in Paediatrics and becoming a full Life Member of the IAP, these members are eligible to become full Life Members of the PHO Chapter. This will be done only on written request of the individual member. Associate members have no voting rights nor are they eligible to hold office in the chapter but will have all the other benefits of chapter membership.
Honoured members of other specialities who work closely with or treat children with haematology oncology disorders (Radiation Oncologists, Pathologists, Paediatric surgeons etc) but are not eligible to be full Life members of IAP, will be Affiliate Life Members. They can, if elected, head any scientific group or committee, as decided from time to time, of the PHO chapter. They will however, not have any voting rights, nor can they hold administrative office in the PHO Chapter.
 
 

Research

  1. Home
  2. Research
  • Varnimcabtagene autoleucel in relapsed or refractory B-cell malignancies
  • Long term outcomes of the Indian childhood cancer survivorship (C2S) cohort: a multicentre study (2016–2024)
  • Subclinical Cardiac Dysfunction in Childhood Cancer Survivors: Insights from Global Longitudinal Strain and Risk Factor Profiling
  • A Comprehensive 360° Philanthropic Support Model: Holistic and Sustainable Approaches to Childhood Cancers (0–19 years) in a Tertiary Cancer Hospital in India
  • Toxicity during induction of pulsed versus continuous prednisolone in children with acute lymphoblastic leukaemia: a multi-centre, open label, randomised, phase 3 trial from India (2016–2022)
  • A double blind RCT to examine the safety and efficacy of Lactobacillus rhamnosus GG in pediatric febrile neutropenia
  • Bridging gaps in oncofertility: evaluation of reproductive dysfunction and fertility assessment in pediatric cancer survivors
  • Pearson Syndrome: Diagnostic Challenges and a Case of Successful Haploidentical Hematopoietic Stem Cell Transplantation
  • Use of Oral Metformin Therapy for Therapy-Induced Hyperglycemia in Pediatric Patients With Acute Lymphoblastic Leukemia
  • Intravenous Fosaprepitant Versus Oral Aprepitant for Children Receiving Highly Emetogenic Chemotherapy: An Investigator-Initiated Randomized, Open-Label, Non-Inferiority Trial
  • Prospective Collaborative Study for Pulse Dexamethasone and Lenalidomide in Relapsed/Refractory Langerhans Cell Histiocytosis (LENDEX-LCH Study): INPHOG-HIST-19-03 (CTRI/2020/07/026937)
  • A Journey of the Pediatric Hematology Oncology (PHO) Chapter of the Indian Academy of Pediatrics (IAP): From Humble Beginnings to Global Influence
  • PREPARE ALL: An Artificial Intelligence Tool for Predicting Relapse in Children With Acute Lymphoblastic Leukemia
© 2026 PHOIndia. All Rights Reserved.
  • Built by vdpl